About Us
Company Overview
Leadership Team
Scientific Advisory Board
Mission, Vision and Values
Our ESG Principles
Our Science
ALPHA
BETA
SIGMA
Publications
Presentations
Our Pipeline
Overview
KESONOTIDE™ and ALPHA-D3
BETA-TT8 Eyedropper Gel
BETA-TT8 Oral
BETA-TT17 Cancer
SIGMA-06G
Clinical Trials
Investors
Announcements
Corporate Presentations
Glossary
Corporate Governance
News & Media
Contact
Our Science
Subscribe to receive
the latest news and updates
Phone
This field is for validation purposes and should be left unchanged.
First Name
(Required)
Last Name
(Required)
Email
(Required)
Δ
